KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Inovio Pharmaceuticals (INO) Return on Assets (2016 - 2025)

Inovio Pharmaceuticals' Return on Assets history spans 15 years, with the latest figure at 1.19% for Q2 2025.

  • For Q2 2025, Return on Assets changed N/A year-over-year to 1.19%; the TTM value through Jun 2025 reached 1.19%, changed N/A, while the annual FY2024 figure was 0.76%, 24.0% down from the prior year.
  • Return on Assets for Q2 2025 was 1.19% at Inovio Pharmaceuticals, down from 1.02% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.22% in Q2 2021 and bottomed at 1.19% in Q2 2025.
  • The 5-year median for Return on Assets is 0.76% (2022), against an average of 0.73%.
  • The largest annual shift saw Return on Assets surged 35bps in 2021 before it tumbled -56bps in 2022.
  • A 5-year view of Return on Assets shows it stood at 0.59% in 2021, then decreased by -28bps to 0.75% in 2022, then increased by 1bps to 0.74% in 2023, then plummeted by -32bps to 0.98% in 2024, then dropped by -21bps to 1.19% in 2025.
  • Per Business Quant, the three most recent readings for INO's Return on Assets are 1.19% (Q2 2025), 1.02% (Q1 2025), and 0.98% (Q4 2024).